Cite
HARVARD Citation
Chen, S. et al. (2022). The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double‐blind multicentre study. Alimentary pharmacology & therapeutics. 55 (12), pp. 1524-1533. [Online].